Validation pré-clinique de fragments d'anticorps anti-idiotypiques mimant l'antigène tumoral HER2 pour la vaccination anti-tumorale – IDHER2VAC
Project coordination
Isabelle TEULON (Organisme de recherche)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 148,200 euros
Beginning and duration of the scientific project:
- 18 Months